glp-1 eye The Impact of Receptor Agonists on Ocular Disease Possible Link Between GLP-1 RA
Description
Their mechanism of action involves the release of insulin, in the presence of elevated glucose concentrations, thus decreasing glucagon secretion
(This does not include cholecystectomy, or gallbladder removal.) Severe gastrointestinal disease, such as ulcerative colitis or gastroparesis
This is in line with evidence that intraduodenal lipid emulsion in rats increases GLP-1 secretion in a dose dependent manner [16]
therefore, continued preclinical and clinical research will be necessary for understanding the mechanisms of success to find a simpler strategy for weight loss and metabolic health
